Investigational Zika vaccine receives Fast Track designation
An investigational Zika vaccine currently being evaluated in a Phase I study has been given a Fast Track designation by the FDA.
List view / Grid view
An investigational Zika vaccine currently being evaluated in a Phase I study has been given a Fast Track designation by the FDA.